Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.

Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL. Clin Lymphoma Myeloma Leuk. 2024 02; 24(2):83-93.

View in: PubMed

subject areas

Fluorodeoxyglucose F18
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse
Neoplasm Recurrence, Local
Prognosis
Retrospective Studies
Tumor Burden

authors with profiles

Andrzej Jakubowiak
Benjamin Derman
Mariam Nawas
Yonglin Pu
Daniel Appelbaum
Peter Riedell
Satyajit Kosuri
Nicholas Feinberg